167 related articles for article (PubMed ID: 29166793)
1. The use and discontinuation of hormone replacement therapy in women in South China.
Chu K; Song Y; Chatooah ND; Weng Q; Ying Q; Ma L; Qu F; Zhou J
Climacteric; 2018 Feb; 21(1):47-52. PubMed ID: 29166793
[TBL] [Abstract][Full Text] [Related]
2. Knowledge and attitude towards menopause and hormone replacement therapy in Chinese women.
Jin F; Tao M; Teng Y; Shao H; Li C; Mills E
Gynecol Obstet Invest; 2015; 79(1):40-5. PubMed ID: 25277502
[TBL] [Abstract][Full Text] [Related]
3. Menopausal symptoms in mid-life women in southern China.
Yang D; Haines CJ; Pan P; Zhang Q; Sun Y; Hong S; Tian F; Bai B; Peng X; Chen W; Yang X; Chen Y; Feng H; Zhao S; Lei H; Jiang Z; Ma X; Liao W
Climacteric; 2008 Aug; 11(4):329-36. PubMed ID: 18645699
[TBL] [Abstract][Full Text] [Related]
4. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
Øren A
Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and symptom reporting in menopausal women: a population-based study of 35-65-year-old women in mid-Sweden.
Bardel A; Wallander MA; Svärdsudd K
Maturitas; 2002 Jan; 41(1):7-15. PubMed ID: 11809338
[TBL] [Abstract][Full Text] [Related]
6. Compliance considerations with hormone replacement therapy.
Karakoç B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
7. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy.
Ettinger B; Pressman A; Silver P
Menopause; 1999; 6(4):282-9. PubMed ID: 10614674
[TBL] [Abstract][Full Text] [Related]
8. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
Lam PM; Leung TN; Haines C; Chung TK
Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
[TBL] [Abstract][Full Text] [Related]
9. A menopause survey of women with benign breast disease history in northwest China.
Gou WJ; Zhao JZ; Zhang R; Yang T; Wang LY; Zhang XH
Climacteric; 2019 Dec; 22(6):622-626. PubMed ID: 31240961
[No Abstract] [Full Text] [Related]
10. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs.
Jacobs PA; Hyland ME
Maturitas; 2003 Dec; 46(4):273-81. PubMed ID: 14625124
[TBL] [Abstract][Full Text] [Related]
11. [Effects of estrogen replacement therapy on reactivity to stress in menopausal women with and without hot flushes].
Leal Hernández M; García Sánchez FA; Martínez Selva JM; Abellán Alemán J
Med Clin (Barc); 2002 Oct; 119(11):410-2. PubMed ID: 12381274
[TBL] [Abstract][Full Text] [Related]
12. What factors account for hormone replacement therapy prescribing frequency?
Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
[TBL] [Abstract][Full Text] [Related]
13. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with treatment options among menopausal women in Taiwan.
Chiou YW; Tai CJ; Chien LY
Maturitas; 2006 Jun; 54(3):205-12. PubMed ID: 16303267
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of symptoms possibly related to the climacteric in pre- and postmenopausal women in Linköping, Sweden.
Jansson C; Johansson S; Lindh-Astrand L; Hoffmann M; Hammar M
Maturitas; 2003 Jun; 45(2):129-35. PubMed ID: 12787971
[TBL] [Abstract][Full Text] [Related]
16. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
17. Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up.
Perrone G; Capri O; Galoppi P; Patacchioli FR; Bevilacqua E; de Stefano MG; Brunelli R
Gynecol Obstet Invest; 2013; 76(1):38-43. PubMed ID: 23711663
[TBL] [Abstract][Full Text] [Related]
18. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, severity, and associated factors of menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study in southeast China.
Lan Y; Huang Y; Song Y; Ma L; Chen P; Ying Q; Li W; Cai Y; Zhou J
Menopause; 2017 Oct; 24(10):1200-1207. PubMed ID: 28609386
[TBL] [Abstract][Full Text] [Related]
20. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
